| AML | acute myeloid leukaemia |
| APCs | antigen-presenting cells |
| BCR | B-cell receptor |
| Bregs | regulatory B cells |
| CAF | cancer-associated fibroblasts |
| CRC | colorectal cancer |
| CSCs | cancer stem cells |
| CTLs | cytotoxic T lymphocytes/CD8+ T lymphocytes/CD8+ T cells |
| DAMPs | damage-associated molecular patterns |
| DCs | dendritic cells |
| ECM | extracellular matrix |
| EGF | epidermal growth factor |
| ICI | immune checkpoint inhibitor |
| IDO | indoleamine 2,3-dioxygenase |
| IFN | Interferon |
| IIC | infiltrating immune cells |
| IL | Interleukin |
| ILCs | innate lymphoid cells |
| IR | immune response |
| IS | immune system |
| LTis | lymphoid-tissue inducer cells |
| MCs | mast cells |
| MDSCs | myeloid-derived suppressor cells |
| MHC-I/-II | major histocompatibility complex-I/-II |
| NK cells | natural killer cells |
| NSCLC | non-small-cell lung cancer |
| PAMPs | pathogen-associated molecular patterns |
| PDAC | pancreatic ductal adenocarcinoma |
| PD-1 | programmed cell death protein 1 |
| PGE2 | prostaglandin E2 |
| ROS/RNS | reactive oxygen species/reactive nitrogen species |
| SCC | squamous cell carcinoma |
| TCR | T-cell receptor |
| TGF | transforming growth factor |
| Th | T helper/CD4+ T lymphocytes/CD4+ T cells |
| TIL B cells | tumour-infiltrating B cells |
| TLRs | toll-like receptors |
| TME | tumour microenvironment |
| TNF | tumour necrosis factor |
| Treg | regulatory T cells |
| VEGF | endothelial growth factor |